SARASOTA, Fla.--(BUSINESS WIRE)--Akron Bio, a leading developer and manufacturer of critical building blocks used by biopharma to produce advanced therapies for the prevention and treatment of ...
MINNEAPOLIS, Dec. 9, 2025 /PRNewswire/ -- Bio-Techne Corporation, a global provider of life science tools, reagents, and diagnostic products, today announced the expanded launch and first shipment of ...
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access ...
Encouraging findings in heavily pretreated patients in multiple solid tumor indications, including MSS colorectal cancer (CRC), in ongoing Phase 1 Part 1b study evaluating NGM707, a dual ILT2/ILT4 ...
Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, achieves technical breakthrough enabling protease-free, same-slide detection of protein and RNA biomarkers using industry-leading ...
Clinical Trials Arena on MSN
Massive Bio partners with OpenAI to broaden clinical trial access
Through working with OpenAI, Massive Bio converts complex clinical trial criteria into machine-readable formats.
The drug is under Priority Review by the U.S. Food and Drug Administration (FDA) and has a Prescription Drug User Fee Act (PDUFA) date of June 23, 2025 The materials will be made available in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results